Stanley-Laman Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-68,771
| Closed | -$6.27M | – | 249 |
|
|
2020
Q4 | $6.27M | Sell |
68,771
-190
| -0.3% | -$17.3K | 1.11% | 28 |
|
|
2020
Q3 | $5.5M | Sell |
68,961
-1,946
| -3% | -$155K | 1.21% | 25 |
|
|
2020
Q2 | $4.9M | Buy |
70,907
+728
| +1% | +$50.3K | 1.18% | 26 |
|
|
2020
Q1 | $4.41M | Buy |
70,179
+67,296
| +2,334% | +$4.23M | 1.34% | 18 |
|
|
2019
Q4 | $224K | Sell |
2,883
-819
| -22% | -$63.6K | 0.05% | 261 |
|
|
2019
Q3 | $271K | Sell |
3,702
-702
| -16% | -$51.4K | 0.07% | 226 |
|
|
2019
Q2 | $271K | Buy |
+4,404
| New | +$271K | 0.07% | 235 |
|
|
2017
Q1 | – | Sell |
-12,000
| Closed | -$375K | – | 252 |
|
|
2016
Q4 | $375K | Hold |
12,000
| – | – | 0.12% | 200 |
|
|
2016
Q3 | $482K | Hold |
12,000
| – | – | 0.2% | 142 |
|
|
2016
Q2 | $399K | Hold |
12,000
| – | – | 0.16% | 168 |
|
|
2016
Q1 | $353K | Hold |
12,000
| – | – | 0.07% | 194 |
|
|
2015
Q4 | $316K | Hold |
12,000
| – | – | 0.05% | 263 |
|
|
2015
Q3 | $284K | Hold |
12,000
| – | – | 0.06% | 254 |
|
|
2015
Q2 | $285K | Hold |
12,000
| – | – | 0.05% | 248 |
|
|
2015
Q1 | $285K | Hold |
12,000
| – | – | 0.05% | 253 |
|
|
2014
Q4 | $255K | Hold |
12,000
| – | – | 0.05% | 271 |
|
|
2014
Q3 | $204K | Buy |
+12,000
| New | +$204K | 0.04% | 272 |
|